%PDF-1.5% 375 0 objendobj 389 0 obj/Filter/FlateDecode/ID[]/Index[375 27]/Info 374 0 R/Length 74/Prev 92811/Root 376 0 R/Size 402/Type/XRef/W[1 2 1]stream hbbd“b`z$; z H0$@XPÙ€,FÒˆ
Bioanalytical Method Validation [Revised Final]
%PDF-1.5% 165 0 objendobj 171 0 obj/Filter/FlateDecode/ID[]/Index[165 19]/Info 164 0 R/Length 52/Prev 124878/Root 166 0 R/Size 184/Type/XRef/W[1 2 1]stream hbbd“b` Hl@UF#iFo
Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application
%PDF-1.5% 1297 0 objendobj 1303 0 obj/Filter/FlateDecode/ID[]/Index[1297 20]/Info 1296 0 R/Length 53/Prev 124418/Root 1298 0 R/Size 1317/Type/XRef/W[1 2 1]stream hbbd“b`6 H|lǵL,F20
Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations
%PDF-1.5% 146 0 objendobj 153 0 obj/Filter/FlateDecode/ID[]/Index[146 20]/Info 145 0 R/Length 56/Prev 169540/Root 147 0 R/Size 166/Type/XRef/W[1 2 1]stream hbbd“b`6!@Ľ$ؾ
Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment
%PDF-1.5% 99 0 objendobj 105 0 obj/Filter/FlateDecode/ID[]/Index[99 17]/Info 98 0 R/Length 52/Prev 80125/Root 100 0 R/Size 116/Type/XRef/W[1 2 1]stream hbbd“b`:$C+`v@;#’#1Æ”
Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Agents for Treatment
%PDF-1.6% 141 0 objendobj 148 0 obj/Filter/FlateDecode/ID[]/Index[141 20]/Info 140 0 R/Length 55/Prev 259003/Root 142 0 R/Size 161/Type/XRef/W[1 2 1]stream hbbd“b`^$@3{HM
Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment
%PDF-1.5% 203 0 objendobj 210 0 obj/Filter/FlateDecode/ID[]/Index[203 20]/Info 202 0 R/Length 57/Prev 195825/Root 204 0 R/Size 223/Type/XRef/W[1 2 1]stream hbbd“b`@HÓ€D Q-RH@
New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products
%PDF-1.5% 455 0 objendobj 461 0 obj/Filter/FlateDecode/ID[]/Index[455 15]/Info 454 0 R/Length 53/Prev 90230/Root 456 0 R/Size 470/Type/XRef/W[1 2 1]stream hbbd“b` $W@H
Qualification Process for Drug Development Tools: (Attachment) Qualification of Exacerbations of Chronic Pulmonary Disease Tool for Measurement of Symptoms of Acute Bacterial Exacerbation of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease
%PDF-1.6% 48 0 objstream hD 0@6*”Bi7)”b xr= :VzÉXu:h: Y:u#+ kvs|Ji|JpRÅ…Erl 4qR`hE{h8N`g9M^
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use — Small Entity Compliance Guide
%PDF-1.4% 60 0 objendobj xref 60 16 0000000016 00000 n 0000001000 00000 n 0000001081 00000 n 0000001211 00000 n 0000001344 00000 n 0000001897 00000 n 0000002348 00000 n 0000002383 00000 n 0000002650 00000 n 0000002906 00000 n 0000002983 00000 n 0000003712 00000 n 0000004249 00000 n 0000004498 00000 n 0000007191 00000 n 0000000616 00000 n…